DTSQ

Overview

DTSQ is a Cayman Islands exempted company with limited liability formed as a blank‑check company to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more target businesses.

IPO and funding

• Initial public offering: 6,900,000 units sold on July 26, 2024 (including full exercise of underwriters’ over‑allotment option for 900,000 units); gross proceeds of $69,000,000.
• Private placement: 206,900 private units sold to the sponsor at $10.00 per unit; gross proceeds of $2,069,000.
• Trust: Approximately $69,000,000 of net proceeds deposited in a trust account for public shareholders; Wilmington Trust National Association serves as trustee.
• Trading: Units listed on Nasdaq as DTSQU. On September 16, 2024, separate trading of underlying components began: ordinary shares (DTSQ) and rights (DTSQR); non‑separated units continue to trade as DTSQU.

Purpose and strategy

Management is actively seeking a target company in any industry or geography. The company intends to use the sponsor and management team’s deal execution capabilities, industry relationships, and capital markets experience to identify and complete a business combination that offers attractive economics and growth potential. DTSQ will consider transactions that provide a clear public‑market path and strategic advantages for the target.

Capital structure and ownership

• Founders: 1,725,000 founder shares issued to initial shareholders for an aggregate $25,000 (approximately $0.014 per share) between November 2022 and January 2024.
• Public securities: Units and their separated components trade in the public market; public shareholders have redemption rights under the trust structure.
• Private units: 206,900 private units issued to the sponsor at $10.00 per unit.
• Rights and warrants: Rights and warrants are part of the capital structure and may be exercised or converted in connection with a business combination pursuant to their governing terms.
• Extension mechanics: The company had an initial 15 months to complete a business combination, with the option to extend to October 26, 2026 by depositing $75,000 per one‑month extension for all remaining public shares into the trust.

Target selection and criteria

• No industry or geographic constraints; targets will be evaluated in part based on a requirement that 80% of the trust balance be represented in fair market value at the time of a definitive agreement when Nasdaq‑listed target rules apply.
• Typical target characteristics the company seeks: established businesses with long‑term financial visibility and recurring cash flow, defensible market positions, growth opportunities from capital investment, and management teams with proven track records and appropriate incentives.
• Transaction flexibility: DTSQ may pursue a 100% acquisition or a combination where not all of the target is acquired; post‑transaction ownership may leave pre‑transaction public shareholders in minority positions depending on valuations.
• Deal execution: The company sources opportunities through the sponsor, affiliates, investment banks, private equity and venture capital networks, lenders and other market participants. Finder’s or consulting fees may be negotiated at arm’s length.
• Financing considerations: If a target requires a minimum cash or net‑worth threshold at closing, redemptions could affect the ability to complete the transaction; alternative financing may be sought where necessary.

Current status and agreements

• Management is actively searching for targets.
• Business Combination Agreement dated February 2, 2026: entered with DTSQ Purchaser Inc. (Delaware) and PrimeGen US, Inc. The contemplated structure included a redomestication merger and an acquisition merger resulting in PrimeGen US, Inc. surviving the acquisition and issuance of Purchaser Class A/B common stock and Non‑Redemption Warrants to certain holders. The business combination contemplated by the agreement had not been consummated as of the filing date.

Financial position and operating history

• DTSQ has not operated an ongoing business prior to a completed business combination and had no revenues before any business combination.
• Liquidity: Substantial funds remain in the trust account for public shareholders. A portion of net proceeds ($2,069,000 from the private placement) was released from the trust to fund operating needs and is available for working capital; the balance remains in trust.
• The auditor’s report includes a going concern paragraph, and the company has stated it may need additional financing to complete a business combination. If the company cannot complete a transaction by the applicable deadlines, funds may be redeployed or liquidated and public shareholders would be entitled to redemption or liquidating distributions under the trust provisions.

Employees and governance

• Executive officers: Sam Zheng Sun (Chairman and CEO), Kenneth Lam (CFO and Director), Jiayi Liang (COO).
• Independent directors: Shaoke Li, Longjiao Li, Chi Zhang, Xunyong Zhou.
• Prior to a business combination, the company does not maintain full‑time operating staff beyond its executive officers.
• Principal office: 31 Hudson Yards, New York, NY. Office space and related services are provided to a sponsor affiliate at $10,000 per month after listing.

Other considerations

• Regulatory and cross‑border risks: The company discusses frameworks such as HFCAA and CFIUS and other PRC‑related risks that could affect China‑linked targets, cross‑border transactions, and future operations.
• Legal regime: DTSQ is governed by Cayman Islands law; investors should consider differences in shareholder protections and enforcement mechanisms compared with U.S. jurisdictions.
• Post‑combination compliance: Following a business combination, the combined public company would prepare financial statements under U.S. GAAP or IFRS, and historical financials may need audit work that complies with PCAOB standards. The combined entity would also need to address Sarbanes‑Oxley internal control requirements as applicable.

Summary

• DTSQ is a Cayman‑domiciled SPAC formed to pursue a business combination across industries and geographies.
• It raised $69.0 million in an IPO and $2.069 million in a private placement; most proceeds are held in trust for public shareholders, with $2.069 million available outside the trust for working capital.
• The company has no operating business or revenue prior to a business combination.
• A business combination with PrimeGen US, Inc. was contemplated under a February 2026 agreement but had not been completed as of the filing date.
• Management emphasizes flexible deal sourcing and transaction structures while recognizing regulatory and liquidity considerations that could affect completion of a transaction.